EN
French
Brimonidine Tartrate Ophthalmic Solution
UPC:
361314144058
Part #:
1074410
Legacy #:
RX-1042
Form:
Ophthalmic Solution (Drops)
NDC:
61314-0144-05
UPC:
324208411100
Part #:
1306924
Legacy #:
324208411100
Form:
Ophthalmic Solution (Drops)
NDC:
24208-0411-10
UPC:
361314143105
Part #:
1029588
Legacy #:
006-3482411-00, 1060054, 3053381, 361314143105
Form:
Ophthalmic Solution (Drops)
NDC:
61314-0143-10
UPC:
324208411155
Part #:
1029589
Legacy #:
006-3482437-00, 103413
Form:
Ophthalmic Solution (Drops)
NDC:
24208-0411-15
UPC:
370069233016
Part #:
1306824
Legacy #:
Form:
Ophthalmic Solution (Drops)
NDC:
70069-0233-01
UPC:
324208411056
Part #:
1099114
Legacy #:
103410, RX-1038
Form:
Ophthalmic Solution (Drops)
NDC:
24208-0411-05
UPC:
361314143051
Part #:
1092787
Legacy #:
006-2703312-00
Form:
Ophthalmic Solution (Drops)
NDC:
61314-0143-05
UPC:
370069231012
Part #:
1306823
Legacy #:
Form:
Ophthalmic Solution (Drops)
NDC:
70069-0231-01
- Alpha-2 adrenergic agonist used to lower intraocular pressure (IOP) in glaucoma and ocular hypertension
- Dual mechanism of action reduces aqueous humor production and increases uveoscleral outflow
- Indicated for long-term IOP management, either as monotherapy or adjunct therapy
- Typically dosed 2–3 times daily, depending on clinical regimen
- Effective add-on therapy when prostaglandins or beta-blockers alone are insufficient
- Available in multiple concentrations (0.2%, 0.15%) to support tolerability and patient-specific needs
- Multi-dose ophthalmic solution designed for consistent and controlled drop delivery
- Widely used across optometry and ophthalmology practices for ongoing glaucoma management
For sale only in the United States.